Skip to results
Modify your search
NARROW
1-20 of 136
Authors: David Schiff
Journal Article
EDITOR'S CHOICE
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Free
Neuro-Oncology, noaf072, https://doi.org/10.1093/neuonc/noaf072
Published: 30 April 2025
Journal Article
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design Get access
Neuro-Oncology, noaf009, https://doi.org/10.1093/neuonc/noaf009
Published: 14 January 2025
Journal Article
Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae186, https://doi.org/10.1093/noajnl/vdae186
Published: 14 December 2024
Journal Article
Brain tumors and fitness to drive: A review and multi-disciplinary approach Get access
Neuro-Oncology Practice, Volume 12, Issue 2, April 2025, Pages 183–196, https://doi.org/10.1093/nop/npae119
Published: 06 December 2024
Journal Article
NCOG-15. CONNECTOME-BASED APPROACHES FOR PRESERVING COGNITIVE FUNCTION AND MINIMIZING DELIRIUM DURING GLIOMA RESECTION: A PILOT STUDY Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii227, https://doi.org/10.1093/neuonc/noae165.0897
Published: 11 November 2024
Journal Article
CTNI-61. PRELIMINARY RESULTS OF A PHASE I/II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii111, https://doi.org/10.1093/neuonc/noae165.0428
Published: 11 November 2024
Journal Article
LTBK-07. PROGRESSION-FREE AND OVERALL SURVIVAL RESULTS OF ECOG-ACRIN E3F05: A PHASE 3 INTERGROUP TRIAL OF RADIATION ± TEMOZOLOMIDE FOR GRADE II GLIOMAS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii1–viii2, https://doi.org/10.1093/neuonc/noae165.1303
Published: 11 November 2024
Journal Article
PATH-07. CLINICAL AND RADIOGRAPHIC FEATURES OF DIFFUSE GLIOMA MOLECULAR SUBTYPES IN ACCORDANCE WITH THE 2021 CNS5 WHO CLASSIFICATION Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii179, https://doi.org/10.1093/neuonc/noae165.0706
Published: 11 November 2024
Journal Article
LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii1, https://doi.org/10.1093/neuonc/noae165.1302
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors Get access
Neuro-Oncology, Volume 26, Issue 12, December 2024, Pages 2159–2173, https://doi.org/10.1093/neuonc/noae128
Published: 29 July 2024
Journal Article
CTNI-53. ESTABLISHING A PHASE I AND RANDOMIZED PHASE II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v87–v88, https://doi.org/10.1093/neuonc/noad179.0335
Published: 10 November 2023
Journal Article
CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi.org/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Journal Article
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v97–v98, https://doi.org/10.1093/neuonc/noad179.0366
Published: 10 November 2023
Journal Article
CTIM-06. A PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GLIOBLASTOMA: EXPLORING THE PROGNOSTIC VALUE OF TREATMENT-INDUCED CD8+CD57+ T-CELLS AS A MARKER FOR SURVIVAL Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v61–v62, https://doi.org/10.1093/neuonc/noad179.0246
Published: 10 November 2023
Journal Article
CTNI-41. PHASE II AND PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v84, https://doi.org/10.1093/neuonc/noad179.0323
Published: 10 November 2023
Journal Article
EDITOR'S CHOICE
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management Free
Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 7–24, https://doi.org/10.1093/neuonc/noad154
Published: 12 September 2023
Journal Article
SDPS-42 METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN EDEMA: A TOPOGRAPHICAL AND CLINICOPATHOLOGIC INVESTIGATION Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Pages iii24–iii25, https://doi.org/10.1093/noajnl/vdad070.096
Published: 04 August 2023
Journal Article
EDITOR'S CHOICE
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review Free
Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1381–1394, https://doi.org/10.1093/neuonc/noad059
Published: 26 April 2023
Journal Article
Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma Free
Neuro-Oncology Practice, Volume 10, Issue 3, June 2023, Pages 291–300, https://doi.org/10.1093/nop/npad008
Published: 11 February 2023
Journal Article
CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii67, https://doi.org/10.1093/neuonc/noac209.261
Published: 14 November 2022
